Aetna said it will sell its Medicare drug plans to WellCare Health Plans as part of a divestiture to help the insurer win Justice Department approval of its sale to CVS Health.
Category: Forbes
Want To Stop Mass Shootings? Do These Two Things, Physician Says
It’s possible to pass laws right now that nearly all Americans support and which will reduce gun violence–if policymakers are willing to do so.
Listen Up, This Hearing Aid Stock Is Set To Take Off
One way to play the tech innovations for hearing aids.
Bending the Health Care Curve toward Personalized Health: Contributed by Dr. Hal Paz, CMO, Aetna
Healthcare, like many other American industries, is moving away from a one-size-fits-all model in favor of highly individualized care that addresses each patient’s unique needs.
Rite Aid Shakes Up Board, Strips CEO Of Chairmanship After Failed Merger
Rite Aid unveiled new governance, stripping CEO John Standley of the company’s chairmanship and adding new board members in the wake of a failed merger and mounting financial losses.
Coca-Cola Dipping Into the Cannabis Infused Drink Market
Long gone are the controversial days of Coca-Cola infusing cocaine into its popular product, now they’ve turned their attention to cannabis. If the company is able to capture just 10% of the projected market size, it would bring in $2.2 billion in reve…
Alnylam Posts Positive Data On Second Drug, Plans FDA Meeting
Alnylam Pharmaceuticals says that its latest experimental drug was successful in a clinical trial, and hopes to ask the Food and Drug Administration to approve the medicine based on that data.
Opioid Lawyers Say Settlement May Hinge On Forcing Plaintiffs Into Class Action
Using the class action mechanism may be the only practical way of ending nearly 2,000 opioid lawsuits, said plaintiff lawyers attending a conference this week.
Aiming To Revolutionize Medical Ultrasound, Butterfly Raises $250 Million At A $1.25 Billion Valuation
The flood of cash represents a victory swashbuckling biotech entrepreneur Jonathan Rothberg who aims to change medical imaging with his $2,000 device. Investors include Fidelity, The Bill & Melinda Gates Foundation, and Fosun Pharma.
Biotechnology Company Maps The Genome To Find The Dark Matter Of Infection
Some of the most amazing research and practical applications in medicine are focused on cracking the genetic code for the good of man. Karius is hard at work to map infection and transform the clinical landscape to save lives.
